.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Colorcon
UBS
Julphar
Farmers Insurance
Healthtrust
Daiichi Sankyo
Express Scripts
Teva

Generated: September 19, 2017

DrugPatentWatch Database Preview

DECADRON W/ XYLOCAINE Drug Profile

« Back to Dashboard

What is the patent landscape for Decadron W/ Xylocaine, and what generic Decadron W/ Xylocaine alternatives are available?

Decadron W/ Xylocaine is a drug marketed by Merck and is included in one NDA.

The generic ingredient in DECADRON W/ XYLOCAINE is dexamethasone sodium phosphate; lidocaine hydrochloride. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; lidocaine hydrochloride profile page.

Summary for Tradename: DECADRON W/ XYLOCAINE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list72
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DECADRON W/ XYLOCAINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
DECADRON W/ XYLOCAINE
dexamethasone sodium phosphate; lidocaine hydrochloride
INJECTABLE;INJECTION013334-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
UBS
Argus Health
Colorcon
Fuji
Deloitte
Boehringer Ingelheim
Accenture
Chubb
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot